NLA focused update on the use of Lp(a) in clinical practice (2024)

Koschinsky, Bajaj, Boffa and colleagues, Journal of Clinical Lipidology 2024: measure Lp(a) at least once in every adult; below 75 nmol/L (30 mg/dL) low risk, 75 to 125 intermediate, 125 nmol/L (50 mg/dL) or more high; cascade screening of first-degree relatives; early intensive risk-factor management; apheresis for the approved indication.